Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

📆 9/21/2023 10:07 PM
📰 medical_xpress

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Tennessee last year spent $48 million on a single drug, Humira—about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, hit the market for as little as $995 a month, the opportunity for savings appeared ample and immediate.

retrieved 21 September 2023 from https://medicalxpress.com/news/2023-09-billions-humira-drug-brokers-americans.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Business Business Latest News, Business Business Headlines